CARLSBAD, Calif., Feb. 23 /PRNewswire/ -- Chiltern International is pleased to announce that Patricia Lovell-Hoare, Head of International Regulatory Affairs, will be speaking at the upcoming 4th National Conference on Managing Legal Risks in Conducting & Promoting Clinical Trials in a session entitled Conducting Clinical Trials Internationally: Pitfalls and Smart Practices.
The conference will be held in the Westin New York at Times Square, New York on February 27 - 28, 2006 and will feature contributions from leading health care, regulatory, food and drug, and product liability attorneys, as well as legal and compliance experts from pharmaceutical, biotech, and medical device companies, CROs, IRBs, hospitals, and research institutions.
Patricia’s presentation “How to Minimize Legal Risk” will focus on a range of issues critical to the success of international clinical trials, including how to comply with U.S. laws and regulations while simultaneously meeting the requirements of other relevant international regulatory bodies.
“A growing number of clinical trials are being run on a global basis and it is essential that sponsors fully appreciate the legal requirements of each region involved,” commented Patricia Lovell-Hoare. “They must ensure that the relevant competent authorities are fully satisfied so that trials can be run to the highest possible standards.”
About Patricia Lovell Hoare, LLB
Patricia Lovell-Hoare is Head of International Regulatory Affairs at Chiltern International. Her role covers the coordination and preparation of worldwide Market Authorization Applications, including National Applications, European MRP, CP and NDA in the US. She also advises clients on product research and development plans, structuring regulatory architecture on a product specific basis, international advertising, regulations and standards for medicinal products, post marketing requirements and pharmacovigilance procedures, data protection and pricing and reimbursement.
About our company:
Established in London in 1982, clinical research organization Chiltern International provides support for clinical operations, project management, data management, biostatistics, medical writing, quality assurance and regulatory and medical affairs services to the pharmaceutical, biotechnology and medical device industries.
The company works both on a local and global basis and provides support for contracted out projects plus contracted in teams for pharmaceutical, biotechnology and medical device clients. Chiltern has offices across the USA, Europe, Asia and Africa.
For more information, please contact: Diana Wood Dr Faiz Kermani Chiltern International Inc. Chiltern International Ltd. 2111 Palomar Airport Road 171 Bath Road Suite 200 Slough Carlsbad Berkshire CA 92011 SL1 4AA USA United Kingdom Tel: +1 760 707 5025 Tel: +44 (0)1753 512000 Fax: +1 760 707 5022 Fax: +44 (0)1753 511116 Email: Diana.Wood@chiltern.com Email: Faiz.Kermani@chiltern.com
Chiltern International
CONTACT: Diana Wood, +1-760-707-5025, or fax, +1-760-707-5022,Diana.Wood@chiltern.com Dr Faiz Kermani, +44 (0)1753 512000, or fax, +44(0)1753 511116, Faiz.Kermani@chiltern.com, both of Chiltern International
